Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer
Jincong Q. Freeman, Sri G. Yarlagadda, Aishwarya Atmakuri, Kevin Kalinsky et autres
7 citationsAnnals of Oncology
Sri G. Yarlagadda
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
34Publications signalées
2797Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Renal Transplantation Outcomes and TreatmentsChronic Kidney Disease and DiabetesOrgan Transplantation Techniques and OutcomesDialysis and Renal Disease ManagementAcute Kidney Injury Research
Publications récentes
Pulmonary Embolism in Patients with End-Stage Kidney Disease Starting Dialysis
Kunal N. Patel, Wan‐Chi Chan, Vivek Bhat, Monil Majmundar et autres
0 citationsJAMA Network Open
Nationwide trends and outcomes of percutaneous coronary intervention for stable ischemic heart disease in end-stage kidney disease: a longitudinal study
Rhythm Vasudeva, Harsh Mehta, Wan‐Chi Chan, Sania Jiwani et autres
3 citationsAnnals of Translational Medicine
Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trial
Matthew Kadatz, Scott Klarenbach, Helen So, Fernando C. Fervenza et autres
7 citationsNephrology Dialysis Transplantation
A COMPARISON OF PULMONARY EMBOLISM OCCURRENCE AND OUTCOMES BETWEEN HEMODIALYSIS VS PERITONEAL DIALYSIS PATIENTS
Kunal N. Patel, Wan‐Chi Chan, Monil Majmundar, Sania Jiwani et autres
0 citationsJournal of the American College of Cardiology
TRENDS OF PULMONARY EMBOLISM AND CLINICAL OUTCOMES IN END STAGE KIDNEY DISEASE PATIENTS FROM 2011 TO 2019 IN THE UNITED STATES
Kunal N. Patel, Wan‐Chi Chan, Monil Majmundar, Sania Jiwani et autres
0 citationsJournal of the American College of Cardiology
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
PK Judge, Natalie Staplin, KJ Mayne, Christoph Wanner et autres
121 citationsThe Lancet Diabetes & Endocrinology
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
Natalie Staplin, Richard Haynes, PK Judge, Christoph Wanner et autres
98 citationsThe Lancet Diabetes & Endocrinology
Impact of preexisting coronary artery and peripheral artery disease on outcomes in diabetic patients after kidney transplant
Sania Jiwani, Wan‐Chi Chan, Monil Majmundar, Kunal N. Patel et autres
4 citationsVascular Medicine
Nationwide Trends and Outcomes for Coronary Artery Bypass Grafting in End-Stage Kidney Disease and Stable Coronary Artery Disease
Rhythm Vasudeva, Harsh Mehta, Wan‐Chi Chan, Monil Majmundar et autres
9 citationsThe American Journal of Cardiology
MAJOR CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY AFTER KIDNEY TRANSPLANTATION IN DIABETIC PATIENTS WITH PRE-EXISTING CORONARY ARTERY DISEASE OR PERIPHERAL VASCULAR DISEASE
Sania Pyarali Jiwani, Wan‐Chi Chan, Monil Majmundar, Harsh Mehta et autres
0 citationsJournal of the American College of Cardiology
Burden of Hypertensive Crisis in Patients With End-Stage Kidney Disease on Maintenance Dialysis: Insights From United States Renal Data System Database
Suveenkrishna Pothuru, Wan‐Chi Chan, Harsh Mehta, Mohinder R. Vindhyal et autres
4 citationsHypertension
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.